Skip to main content
Premium Trial:

Request an Annual Quote

U of Bonn Study to Assess VolitionRx Platform for Lung Cancer Dx

NEW YORK (GenomeWeb) – VolitionRx today announced that the University of Bonn in Germany will begin a clinical study to assess VolitionRx's Nucleosomics platform for the diagnosis of lung cancer through a non-invasive blood test.

The study will be conducted as a separate trial in conjunction with the firm's larger 4,000-subject prospective study at University Hospital Bonn, evaluating NuQ assays in the 20 most prevalent cancers.

"The use of promising biomarkers such as modifications of nucleosomes – which play an important role in the development and progression of lung cancer – may offer the potential to enhance the accuracy of early cancer detection," said Stefan Holdenrieder, who will lead the study.

Previously, the firm has worked with Oxford University, the University of Texas MD Anderson Cancer Center, and the University of Copenhagen's Hvidovre Hospital to evaluate the Nucleosomics platform and NuQ assays.

Singapore-based VolitionRx's NuQ tests utilize the firm's proprietary Nucleosomics platform, which identifies and measures circulating nucleosome structures for the presence of epigenetic cancer and signals in blood and in sputum.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.